Literature DB >> 582233

Peliosis hepatis. Report of nine cases.

T Karasawa, T Shikata, R D Smith.   

Abstract

Nine cases of peliosis hepatis are reported: five of these were associated with the administration of androgen or anabolic androgenic steroids and a sixth with large doses of medroxy-progesterone acetate. In five instances, neoplasm was present as an underlying disease. Antemortem evidence of liver disease was detected in six of seven cases but was not severe and had not contributed to death. The pathogenesis of blood-filled cystic cavities is discussed and the literature reviewed. Angiopathy of hepatic sinusoids in patients with wasting diseases or in those receiving androgens in coexistence with passive congestion of the liver appear to be factors in the pathogenesis of pleiosis hepatis.

Entities:  

Mesh:

Year:  1979        PMID: 582233     DOI: 10.1111/j.1440-1827.1979.tb00201.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  6 in total

Review 1.  Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2008-07-02       Impact factor: 4.492

Review 2.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

3.  Excessive tumor-elaborated VEGF and its neutralization define a lethal paraneoplastic syndrome.

Authors:  A K Wong; M Alfert; D H Castrillon; Q Shen; J Holash; G D Yancopoulos; L Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

4.  Clinicopathological study of hepatocellular carcinoma with peliotic change.

Authors:  Masaru Fujimoto; Osamu Nakashima; Mina Komuta; Toshimitsu Miyaaki; Masamichi Kojiro; Hirohisa Yano
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

5.  Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome.

Authors:  Yuan Xue; Piotr Religa; Renhai Cao; Anker Jon Hansen; Franco Lucchini; Bernt Jones; Yan Wu; Zhenping Zhu; Bronislaw Pytowski; Yuxiang Liang; Weide Zhong; Paolo Vezzoni; Björn Rozell; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

Review 6.  Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics.

Authors:  Miren García-Cortés; Mercedes Robles-Díaz; Aida Ortega-Alonso; Inmaculada Medina-Caliz; Raul J Andrade
Journal:  Int J Mol Sci       Date:  2016-04-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.